Together with resmetirom, a selective thyroid hormone receptor- (THR-) agonist, semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) [3, 4], has shown promising results in phase II and phase III trials
Key considerations include: The mechanism by which these medications affect metabolic and hormonal pathways Potential direct or indirect effects on conception and early embryonic development The duration these medications remain in the body after discontinuation Individual patient factors, including BMI, underlying health conditions, and fertility status It's important to note that improved weight and metabolic control may restore ovulation in some women, particularly those with obesity or polycystic ovary syndrome (PCOS)
To protect your metabolism and muscles, make sure you: Eat at least 100130g of protein daily Strength train 24x/week Stay hydrated and monitor electrolytes Prioritize real food over ultra-processed options Track muscle loss and body comp, not just scale weight Focus on building sustainable routines Whether youre using GLP-1 medication or not, your food choices matter
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
Its compact structure resists enzymatic degradation, enabling long-duration laboratory studies of fat metabolism
TABLE 4-1 AF Benefits from FY2013 Transitions SOURCE: Air Force SBIR Briefing for NRC Staff, June 2014